Claudia Rafful1,2, Jason Melo1, María Elena Medina-Mora3, Gudelia Rangel4,5, Xiaoying Sun6, Sonia Jain6, Dan Werb1,7. 1. Division of Global Public Health, University of California San Diego, San Diego, USA. 2. Department of Public Health, San Diego State University, San Diego, USA. 3. National Institute of Psychiatry, Mexico City, Mexico. 4. Secretariat of Health, Mexico City, Mexico. 5. Mexico-United States Border Health Commission, Tijuana, Mexico. 6. Department of Family Medicine and Public Health, Biostatistics Research Center, University of California San Diego, San Diego, USA. 7. Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada.
Abstract
INTRODUCTION AND AIMS: Efforts to prevent injection drug use (IDU) are increasingly focusing on the role that people who inject drugs (PWID) play in facilitating the entry of others into this behaviour. This is particularly relevant in settings experiencing high levels of IDU, such as Mexico's northern border region, where cross-border migration, particularly through forced deportation, has been found to increase a range of health and social harms related to injecting. DESIGN AND METHODS: PWID enrolled in a prospective cohort study in Tijuana, Mexico, since 2011 were interviewed semi-annually, which solicited responses on their experiences initiating others into injecting. Univariate and multivariable logistic regression analyses were conducted at the Preventing Injection by Modifying Existing Responses (PRIMER) baseline, with the dependent variable defined as reporting ever initiating others into injection. The primary independent variable was lifetime deportation from the USA to Mexico. RESULTS: Among 532 participants, 14% (n = 76) reported initiating others into injecting, the majority of participants reporting initiating acquaintances (74%, n = 56). In multivariable analyses, initiating others into injecting was independently associated with reporting living in the USA for 1-5 years [adjusted odds ratio (AOR) = 2.42; 95% confidence interval (CI) 1.22-4.79, P = 0.01], and methamphetamine and heroin injection combined (AOR = 3.67; 95% CI 1.11-12.17, P = 0.03). Deportation was not independently associated with initiating others into injecting. DISCUSSION AND CONCLUSIONS: The impact of migration needs to be considered within binational programming seeking to prevent the expansion of epidemics of injecting and HIV transmission among mobile populations residing in the Mexico-USA border region.
INTRODUCTION AND AIMS: Efforts to prevent injection drug use (IDU) are increasingly focusing on the role that people who inject drugs (PWID) play in facilitating the entry of others into this behaviour. This is particularly relevant in settings experiencing high levels of IDU, such as Mexico's northern border region, where cross-border migration, particularly through forced deportation, has been found to increase a range of health and social harms related to injecting. DESIGN AND METHODS: PWID enrolled in a prospective cohort study in Tijuana, Mexico, since 2011 were interviewed semi-annually, which solicited responses on their experiences initiating others into injecting. Univariate and multivariable logistic regression analyses were conducted at the Preventing Injection by Modifying Existing Responses (PRIMER) baseline, with the dependent variable defined as reporting ever initiating others into injection. The primary independent variable was lifetime deportation from the USA to Mexico. RESULTS: Among 532 participants, 14% (n = 76) reported initiating others into injecting, the majority of participants reporting initiating acquaintances (74%, n = 56). In multivariable analyses, initiating others into injecting was independently associated with reporting living in the USA for 1-5 years [adjusted odds ratio (AOR) = 2.42; 95% confidence interval (CI) 1.22-4.79, P = 0.01], and methamphetamine and heroin injection combined (AOR = 3.67; 95% CI 1.11-12.17, P = 0.03). Deportation was not independently associated with initiating others into injecting. DISCUSSION AND CONCLUSIONS: The impact of migration needs to be considered within binational programming seeking to prevent the expansion of epidemics of injecting and HIV transmission among mobile populations residing in the Mexico-USA border region.
Authors: Jesus Bucardo; Kimberly C Brouwer; Carlos Magis-Rodríguez; Rebeca Ramos; Miguel Fraga; Saida G Perez; Thomas L Patterson; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2005-04-01 Impact factor: 4.492
Authors: K C Brouwer; R Lozada; W A Cornelius; M Firestone Cruz; C Magis-Rodríguez; M L Zúñiga de Nuncio; S A Strathdee Journal: J Immigr Minor Health Date: 2008-02-05
Authors: Nooshin Khobzi Rotondi; Carol Strike; Gillian Kolla; Michael A Rotondi; Katherine Rudzinski; Tim Guimond; Elise Roy Journal: AIDS Behav Date: 2014-03
Authors: Meredith C Meacham; Steffanie A Strathdee; Gudelia Rangel; Richard F Armenta; Tommi L Gaines; Richard S Garfein Journal: J Stud Alcohol Drugs Date: 2016-09 Impact factor: 2.582
Authors: Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Jennifer Lorvick; Brendan Quinn; James P Thing; Alex H Kral Journal: Drug Alcohol Depend Date: 2015-02-19 Impact factor: 4.492
Authors: Claudia Rafful; William Zule; Patricia E González-Zúñiga; Dan Werb; María Elena Medina-Mora; Carlos Magis-Rodriguez; Steffanie A Strathdee Journal: Am J Drug Alcohol Abuse Date: 2015-02-19 Impact factor: 3.829
Authors: Stephanie Navarro; Alex H Kral; Carol S Strike; Kelsey Simpson; Lynn Wenger; Ricky N Bluthenthal Journal: Subst Use Misuse Date: 2019-05-03 Impact factor: 2.164
Authors: Charles Marks; Annick Borquez; Sonia Jain; Xiaoying Sun; Steffanie A Strathdee; Richard S Garfein; M-J Milloy; Kora DeBeck; Javier A Cepeda; Dan Werb; Natasha K Martin Journal: PLoS Med Date: 2019-11-26 Impact factor: 11.069
Authors: Sean T Allen; Kristin E Schneider; Alyona Mazhnaya; Rebecca Hamilton White; Allison O'Rourke; Alex H Kral; Ricky N Bluthenthal; Michael E Kilkenny; Susan G Sherman Journal: AIDS Behav Date: 2021-06-02
Authors: Rachel E Gicquelais; Dan Werb; Charles Marks; Carolyn Ziegler; Shruti H Mehta; Becky L Genberg; Ayden I Scheim Journal: Epidemiol Rev Date: 2020-01-31 Impact factor: 4.280